Publications by authors named "Martin Landray"

Claim this Profile
A
A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trial.
Niklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, Rebecca C Harris, Marine Dufournet, Martin J Landray

Am Heart J· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.
Niklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, Rebecca C Harris, Marine Dufournet, Martin J Landray

N Engl J Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysis.
William G Herrington, Zhaojing J Che, Rebecca Sardell, Alistair J Roddick, Parminder K Judge, Martin J Landray

Lancet Diabetes Endocrinol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: The DANFLU-2 Trial Subgroup Analysis.
Katja Vu Bartholdy, Niklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, Rebecca C Harris, Martin J Landray

J Am Coll Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Atrial Fibrillation: A Prespecified Analysis of the DANFLU-2 Trial.
Caroline Espersen, Niklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, Rebecca C Harris, Martin J Landray

J Am Coll Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.
Doreen Zhu, Parminder K Judge, Susan T Francis, Zhaojing Che, Jennifer J Rayner, Martin J Landray

Am J Kidney Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Versus Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 Trial.
Kristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, Rebecca C Harris, Martin J Landray

Circ Heart Fail· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease: the DANFLU-2 trial.
Manan Pareek, Niklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, Rebecca C Harris, Martin J Landray

Eur Heart J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.
Niklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, Rebecca C Harris, Marine Dufournet, Martin J Landray

JAMA Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trial.
Lisa Steen Duus, Niklas Dyrby Johansen, Daniel Modin, Kira Hyldekær Janstrup, Joshua Nealon, Martin J Landray

Respir Investig· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose vs. Standard-Dose Influenza Vaccine in Older Patients With Hypertension: A Post Hoc Analysis of DANFLU-1.
Adam Femerling Langhoff, Niklas Dyrby Johansen, Daniel Modin, Kira Hyldekær Janstrup, Katja Vu Bartholdy, Martin J Landray

J Clin Hypertens (Greenwich)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommended methodologies for clinical investigations of high-risk medical devices-Conclusions from the European Union CORE-MD Project.
Alan G Fraser, Sergio Buccheri, Robert A Byrne, Per Kjaersgaard-Andersen, Stefan James, Martin J Landray

Lancet Reg Health Eur· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose Interference in Urine Biomarkers and Implications for Sodium-Glucose Cotransporter 2 Inhibition.
Greco B Malijan, Daniel Chapman, Stewart Moffat, Rebecca J Sardell, Natalie Staplin, Martin J Landray

Kidney Int Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.
Greco B Malijan, Rebecca J Sardell, Natalie Staplin, Olivier Devuyst, Daniel Chapman, Martin J Landray

Am J Kidney Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to frailty score: A post-hoc analysis of the DANFLU-1 randomized trial.
Caroline Espersen, Niklas Dyrby Johansen, Daniel Modin, Kira Hyldekær Janstrup, Joshua Nealon, Martin J Landray

J Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine: A Prespecified Secondary Analysis of the Randomized DANFLU-2 Trial.
Manan Pareek, Niklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, Rebecca C Harris, Martin J Landray

JAMA Netw Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Junwen Zhou, Claire Williams, Natalie Staplin, Parminder K Judge, Kaitlin J Mayne, Martin J Landray

EClinicalMedicine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.
Parminder K Judge, Katherine R Tuttle, Natalie Staplin, Sibylle J Hauske, Doreen Zhu, Martin J Landray

Nephrol Dial Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Large simple randomized controlled trials-from drugs to medical devices: lessons from recent experience.
Sergio Buccheri, Stefan James, Marion Mafham, Martin Landray, Tom Melvin

Trials· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.

N Engl J Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large simple randomized controlled trials-from drugs to medical devices: lessons from recent experience.
Sergio Buccheri, Stefan James, Marion Mafham, Martin Landray, Tom Melvin

Trials· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: A post hoc analysis of the DANFLU-1 randomized clinical trial.
Jacob Christensen, Niklas Dyrby Johansen, Kira Hyldekær Janstrup, Daniel Modin, Kristoffer Grundtvig Skaarup, Martin J Landray

J Infect· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments.
Caroline Cake, Emma Ogburn, Heather Pinches, Garry Coleman, David Seymour, Martin Landray

Trials· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating evidence generation: Addressing critical challenges and charting a path forward.
Jeeyon G Rim, Jennifer G Jackman, Christoph P Hornik, Joni L Rutter, Haider Warraich, Martin Landray

J Clin Transl Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, Parminder K Judge, Doreen Zhu, Martin J Landray

Clin J Am Soc Nephrol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis